{"disease":{"id":"ovarian-and-fallopian-tube-cysts-and-neoplasms","name":"ovarian and fallopian tube cysts and neoplasms"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04566952","title":"Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":68,"lead_sponsor_name":"Xiaoxiang Chen","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}